Carregant...
Targeting B-cell maturation antigen in multiple myeloma
Novel effective immunotherapies are needed for patients with multiple myeloma (MM), since disease recurrence remains a major obstacle. B-cell maturation antigen (BCMA), a cell surface protein universally expressed on malignant plasma cells , has emerged as a very selective antigen to be targeted in...
Guardat en:
| Publicat a: | Immunotherapy |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976846/ https://ncbi.nlm.nih.gov/pubmed/26370838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.15.77 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|